Research Group
Prostate and Urologic Cancer
Sponsor
University of Alabama at Birmingham
Status
Recruiting
ClinicalTrials.gov ID
For more information, see ClinicalTrials.gov NCT04091022
This is a single institution, randomized, placebo-controlled, double-blind phase IIB trial of
1) topical diclofenac and topical DFMO, or 2) placebo in participants with a history of non
melanoma skin cancer/ keratinocytic cancers.
1) topical diclofenac and topical DFMO, or 2) placebo in participants with a history of non
melanoma skin cancer/ keratinocytic cancers.
Intervention
Solaraze and Vaniqa
Condition
Non-melanoma Skin Cancer
Investigators
Craug Elmets, MD, Craig Elmets, MD